Cytosorbents (CTSO) Net Cash Flow Growth (5y) (2015 - 2026)
Powered by 
Analysis
Cytosorbents (CTSO) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.58% |
| Mar 31, 2026 | 15.92% |
| Dec 31, 2025 | 30.67% |
| Sep 30, 2025 | -15.41% |
| Jun 30, 2025 | -16.97% |
| Mar 31, 2025 | -25.19% |
| Dec 31, 2024 | 9.35% |
| Sep 30, 2024 | -56.64% |
| Jun 30, 2024 | 28.29% |
| Mar 31, 2024 | -15.35% |
| Dec 31, 2023 | 33.36% |
| Sep 30, 2023 | -69.54% |
| Jun 30, 2023 | -27.60% |
| Mar 31, 2023 | -23.08% |
| Dec 31, 2022 | -17.97% |
| Sep 30, 2022 | -48.46% |
| Jun 30, 2022 | -24.33% |
| Mar 31, 2022 | -34.95% |
| Dec 31, 2021 | -45.16% |
| Sep 30, 2021 | -14.63% |